341 related articles for article (PubMed ID: 33891015)
21. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
Kovács GL; De Wied D
Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.
Pierce ML; French JA; Murray TF
Biomed Pharmacother; 2020 Jun; 126():110060. PubMed ID: 32145592
[TBL] [Abstract][Full Text] [Related]
23. Neurohypophyseal peptides in aging and Alzheimer's disease.
Ishunina TA; Swaab DF
Ageing Res Rev; 2002 Jun; 1(3):537-58. PubMed ID: 12067600
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin differentially modulates non-NMDA receptors in vasopressin and oxytocin neurons in the supraoptic nucleus.
Hirasawa M; Mouginot D; Kozoriz MG; Kombian SB; Pittman QJ
J Neurosci; 2003 May; 23(10):4270-7. PubMed ID: 12764115
[TBL] [Abstract][Full Text] [Related]
25. Central oxytocin systems may mediate a cardiovascular response to acute stress in rats.
Callahan MF; Kirby RF; Cunningham JT; Eskridge-Sloop SL; Johnson AK; McCarty R; Gruber KA
Am J Physiol; 1989 May; 256(5 Pt 2):H1369-77. PubMed ID: 2719134
[TBL] [Abstract][Full Text] [Related]
26. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review.
Gibbs DM
Psychoneuroendocrinology; 1986; 11(2):131-9. PubMed ID: 3018820
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a functional relationship between noradrenaline and neurohypophyseal peptides in the brainstem of rats.
Vallejo M; Lightman SL
Brain Res; 1987 Oct; 422(2):295-302. PubMed ID: 3676790
[TBL] [Abstract][Full Text] [Related]
28. Specific expression of optically active reporter gene in arginine vasopressin-secreting neurosecretory cells in the hypothalamic-neurohypophyseal system.
Ueta Y; Fujihara H; Dayanithi G; Kawata M; Murphy D
J Neuroendocrinol; 2008 Jun; 20(6):660-4. PubMed ID: 18601686
[TBL] [Abstract][Full Text] [Related]
29. Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge.
Sherman TG; Day R; Civelli O; Douglass J; Herbert E; Akil H; Watson SJ
J Neurosci; 1988 Oct; 8(10):3785-96. PubMed ID: 2903913
[TBL] [Abstract][Full Text] [Related]
30. Neurohypophyseal peptides as regulators of growth and development. A review.
Carter DA; Fai CK; Murphy D
J Mol Neurosci; 1993; 4(1):11-9. PubMed ID: 8318355
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical investigation of the magnocellular peptidergic hypothalamo-neurohypophysial system of the rat chronically stimulated by long-term administration of hypertonic saline.
Dellmann HD; Rodríguez EM; Peña P; Siegmund I
Neuroendocrinology; 1988 Apr; 47(4):335-42. PubMed ID: 3374758
[TBL] [Abstract][Full Text] [Related]
32. Oxytocin actions within the supraoptic and paraventricular nuclei: differential effects on peripheral and intranuclear vasopressin release.
Neumann ID; Torner L; Toschi N; Veenema AH
Am J Physiol Regul Integr Comp Physiol; 2006 Jul; 291(1):R29-36. PubMed ID: 16424083
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
34. Afferent renal inputs to paraventricular nucleus vasopressin and oxytocin neurosecretory neurons.
Ciriello J
Am J Physiol; 1998 Dec; 275(6):R1745-54. PubMed ID: 9843863
[TBL] [Abstract][Full Text] [Related]
35. Multiple receptor contributions to ovine fetal cardiovascular responses to vasopressin.
Ervin MG; Terry KA; Calvario GC; Ross MG; Leake RD; Fisher DA
Ann N Y Acad Sci; 1993 Jul; 689():504-7. PubMed ID: 8373035
[TBL] [Abstract][Full Text] [Related]
36. The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.
Szczepanska-Sadowska E
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430892
[TBL] [Abstract][Full Text] [Related]
37. Arginine vasopressin (AVP): a review of its historical perspectives, current research and multifunctional role in the hypothalamo-hypophysial system.
Rotondo F; Butz H; Syro LV; Yousef GM; Di Ieva A; Restrepo LM; Quintanar-Stephano A; Berczi I; Kovacs K
Pituitary; 2016 Aug; 19(4):345-55. PubMed ID: 26762848
[TBL] [Abstract][Full Text] [Related]
38. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats.
Whitnall MH
J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632
[TBL] [Abstract][Full Text] [Related]
39. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
40. [Biosynthesis and secretion of vasopressin].
Ban T; Yoshida S
Nihon Rinsho; 1993 Oct; 51(10):2618-23. PubMed ID: 7902879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
